Rite Aid Pharmacy 07700 Durable Medical Equipment & Medical Supplies Location: 7358 Secor Rd, Lambertville, Michigan 48144 Phone: (734) 856-7984 |
Pierce Medical Products Inc. Durable Medical Equipment & Medical Supplies Location: 8535 Secor Rd, Lambertville, Michigan 48144 Phone: (734) 854-7864 |
Kroger Pharmacy 16864 Durable Medical Equipment & Medical Supplies Location: 3462 W Sterns Rd, Lambertville, Michigan 48144 Phone: (734) 854-2690 |
Walgreens #10804 Durable Medical Equipment & Medical Supplies Location: 7420 Secor Rd, Lambertville, Michigan 48144 Phone: (734) 856-2083 |
Robert C Layman Od Medicare Supplier Location: 3309 Quail Hollow Dr, Lambertville, Michigan 48144 Phone: (734) 854-3937 |
News Archive
Labopharm Inc. today announced its wholly owned subsidiary, Labopharm Europe Limited, has completed a distribution and supply agreement with Merck Sharp & Dohme Limited (MSD), a United Kingdom (U.K.) subsidiary of Merck & Co., Inc., under which MSD will distribute and market Tradorec XL(R) (once-daily tramadol based on Labopharm's proprietary Contramid(R) technology).
Researchers have for the first time identified the function of olfactory receptors in the human heart muscle, such as are also present in the nose. One of the receptors reacts to fatty acids that occur in the blood, in patients with diabetes significantly above the normal range.
Bed bugs are back. Since 2000, bed bug infestations have risen 81 percent, according to The National Pest Management Association. This resurgence has consumers nationwide on high alert, seeking information on the pests and how they can protect themselves.
Engineers at the University of California, San Diego have determined for the first time the impact of a ring-shaped vortex on transporting blood flow in normal and abnormal ventricles within the human heart. They worked with cardiologists at the Non-Invasive Cardiology Laboratory at Gregorio Marañon Hospital, in Madrid, Spain.
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.
› Verified 7 days ago